 |
The Journal of Neuroscience, June 9, 2004, 24(23):5439-5444; doi:10.1523/JNEUROSCI.0974-04.2004
Previous Article | Next Article 
Development/Plasticity/Repair
Neurogenic Effect of -Amyloid Peptide in the Development of Neural Stem Cells
Miguel A. López-Toledano and
Michael L. Shelanski
Taub Institute for Research on Alzheimer's Disease and the Aging Brain and Department of Pathology, Columbia University, New York, New York 10032
The adult mammalian brain contains neural stem cells (NSCs) with self-renewal and multilineage potential in the hippocampus and subventricular zone. However, neurogenesis from these areas does not compensate for neuronal loss in age-related neurodegenerative disorders such as Alzheimer's disease (AD). To test whether an impairment of neurogenesis could contribute to the pathogenesis of AD, we examined the effects of amyloid- peptide (A ) on the survival and neuronal differentiation of cultured NSCs from striatum and hippocampus. We show that A peptide does not impair the neurogenic rate in NSC progeny, but that it increases the total number of neurons in vitro in a dose-dependent manner. The neurogenic effect of A peptide is not dependent on soluble factors released from the NSC progeny. Neurogenesis is induced by A 42 and not A 40 or A 25-35, and the activity appears to be a property of A oligomers and not fibrils.
These results suggest that A may have positive as well as deleterious actions, and that a knowledge of the mechanisms involved in the former could be valuable in exploiting the regenerative and plastic potential of the brain in preventing and treating Alzheimer's disease.
Key words: Alzheimer; differentiation; hippocampus; stem cells; neurogenesis; amyloid peptide
Received Nov 24, 2003;
revised May 4, 2004;
accepted May 5, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
T. Ariga, M. P. McDonald, and R. K. Yu
Thematic Review Series: Sphingolipids. Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review
J. Lipid Res.,
June 1, 2008;
49(6):
1157 - 1175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. V. Ermini, S. Grathwohl, R. Radde, M. Yamaguchi, M. Staufenbiel, T. D. Palmer, and M. Jucker
Neurogenesis and Alterations of Neural Stem Cells in Mouse Models of Cerebral Amyloidosis
Am. J. Pathol.,
June 1, 2008;
172(6):
1520 - 1528.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rohe, A.-S. Carlo, H. Breyhan, A. Sporbert, D. Militz, V. Schmidt, C. Wozny, A. Harmeier, B. Erdmann, K. R. Bales, et al.
Sortilin-related Receptor with A-type Repeats (SORLA) Affects the Amyloid Precursor Protein-dependent Stimulation of ERK Signaling and Adult Neurogenesis
J. Biol. Chem.,
May 23, 2008;
283(21):
14826 - 14834.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Uchida, S.-i. Nakano, F. Gomi, and H. Takahashi
Differential Regulation of Basic Helix-Loop-Helix Factors Mash1 and Olig2 by beta-Amyloid Accelerates Both Differentiation and Death of Cultured Neural Stem/Progenitor Cells
J. Biol. Chem.,
July 6, 2007;
282(27):
19700 - 19709.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Becker, V. Lavie, and B. Solomon
Stimulation of endogenous neurogenesis by anti-EFRH immunization in a transgenic mouse model of Alzheimer's disease
PNAS,
January 30, 2007;
104(5):
1691 - 1696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Drachman
Aging of the brain, entropy, and Alzheimer disease
Neurology,
October 24, 2006;
67(8):
1340 - 1352.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|